Page last updated: 2024-08-25

almagate and Neovascularization, Optic Disc

almagate has been researched along with Neovascularization, Optic Disc in 16 studies

Research

Studies (16)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's11 (68.75)29.6817
2010's5 (31.25)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
DeCastro Molina, JA; George, PP; Heng, BH1
Delle Noci, N; Iaculli, C; Prascina, F; Querques, G1
Aguilar, E; Banin, E; Bird, A; Dorrell, MI; Friedlander, M; Gariano, R; Gasmi, M; Heckenlively, J; Jacobson, R; Ramirez, GA; Siuzdak, G; Yanes, O1
Banda, RM; Giuliari, GP; González, VH; Guel, DA1
Thelen, U1
Agostini, HT; Bates, DO; Beazley Long, N; Bevan, HS; Churchill, AJ; Floege, J; Gammons, M; Harper, SJ; Hua, J; Lehrling, C; Magnussen, AL; Rennel, ES1
Dietzel, M; Gutfleisch, M; Heimes, B; Lommatzsch, A; Pauleikhoff, D; Spital, G1
Cortez, MA; Cortez, RT; Giuliari, GP; Guel, DA1
Moshfeghi, AA; Puliafito, CA1
Adamis, AP; Altaweel, M; Barrett, K; Bressler, NM; Cunningham, ET; Davis, MD; Goldbaum, M; Gonzales, C; Guyer, DR; Patel, M1
D'Amico, DJ; Vavvas, D1
Gillies, MC1
Goldbaum, M; Katz, B1
Bansal, AG; Majji, AB; Narayanan, R; Thomas, R1
Ulińska, M1
Pieramici, DJ; Rabena, MD1

Reviews

6 review(s) available for almagate and Neovascularization, Optic Disc

ArticleYear
The methodological quality of systematic reviews comparing intravitreal bevacizumab and alternates for neovascular age related macular degeneration: A systematic review of reviews.
    Indian journal of ophthalmology, 2014, Volume: 62, Issue:7

    Topics: Angiogenesis Inhibitors; Aptamers, Nucleotide; Bevacizumab; Humans; Intravitreal Injections; Macular Degeneration; Retinal Neovascularization; Vascular Endothelial Growth Factor A

2014
Selective and pan-blockade agents in the anti-angiogenic treatment of proliferative diabetic retinopathy: a literature summary.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2010, Volume: 45, Issue:5

    Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Diabetic Retinopathy; Humans; Macular Edema; Ranibizumab; Retinal Neovascularization; Vascular Endothelial Growth Factor A

2010
Pegaptanib sodium for the treatment of neovascular age-related macular degeneration.
    Expert opinion on investigational drugs, 2005, Volume: 14, Issue:5

    Topics: Aptamers, Nucleotide; Clinical Trials as Topic; Humans; Macular Degeneration; Retinal Neovascularization; Vascular Endothelial Growth Factor A; Vitreous Body

2005
Pegaptanib (Macugen): treating neovascular age-related macular degeneration and current role in clinical practice.
    Ophthalmology clinics of North America, 2006, Volume: 19, Issue:3

    Topics: Aptamers, Nucleotide; Humans; Macular Degeneration; Retinal Neovascularization; Treatment Outcome; Vascular Endothelial Growth Factor A

2006
Macugen (pegaptanib sodium), a novel ocular therapeutic that targets vascular endothelial growth factor (VEGF).
    International ophthalmology clinics, 2006,Fall, Volume: 46, Issue:4

    Topics: Aptamers, Nucleotide; Humans; Macular Degeneration; Retinal Neovascularization; Treatment Outcome; Vascular Endothelial Growth Factor A

2006
[Pegaptanib sodium in treatment of wet AMD].
    Klinika oczna, 2006, Volume: 108, Issue:10-12

    Topics: Aptamers, Nucleotide; Humans; Macular Degeneration; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Retinal Neovascularization; Vascular Endothelial Growth Factor A

2006

Trials

1 trial(s) available for almagate and Neovascularization, Optic Disc

ArticleYear
Intravitreal injection of pegaptanib sodium for proliferative diabetic retinopathy.
    The British journal of ophthalmology, 2009, Volume: 93, Issue:11

    Topics: Adult; Aged; Angiogenesis Inhibitors; Aptamers, Nucleotide; Diabetic Retinopathy; Female; Humans; Injections, Intralesional; Laser Coagulation; Male; Middle Aged; Pilot Projects; Prospective Studies; Retinal Neovascularization

2009

Other Studies

9 other study(ies) available for almagate and Neovascularization, Optic Disc

ArticleYear
Intravitreal pegaptanib sodium (Macugen) for radiation retinopathy following episcleral plaque radiotherapy.
    Acta ophthalmologica, 2008, Volume: 86, Issue:6

    Topics: Aptamers, Nucleotide; Brachytherapy; Choroid Neoplasms; Exudates and Transudates; Female; Fluorescein Angiography; Humans; Injections; Melanoma; Middle Aged; Optic Disk; Radiation Injuries; Retina; Retinal Hemorrhage; Retinal Neovascularization; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Vitreous Body

2008
Antioxidant or neurotrophic factor treatment preserves function in a mouse model of neovascularization-associated oxidative stress.
    The Journal of clinical investigation, 2009, Volume: 119, Issue:3

    Topics: Angiogenesis Inhibitors; Animals; Antioxidants; Aptamers, Nucleotide; Disease Models, Animal; Electroretinography; Gene Expression; Gene Expression Profiling; Gene Transfer Techniques; Lipid Peroxidation; Mice; Mice, Inbred C57BL; Mice, Knockout; Nerve Growth Factors; Opsins; Oxidative Stress; Receptors, LDL; Retina; Retinal Cone Photoreceptor Cells; Retinal Neovascularization; Retinal Pigment Epithelium; Retinal Rod Photoreceptor Cells; Retinitis Pigmentosa; Rhodopsin; Vascular Endothelial Growth Factor A

2009
[Clinical experience with pegaptanib in the treatment of age-related macular degeneration (AMD)].
    Klinische Monatsblatter fur Augenheilkunde, 2010, Volume: 227, Issue:1

    Topics: Aged; Aged, 80 and over; Aptamers, Nucleotide; Female; Fluorescein Angiography; Humans; Injections; Intraocular Pressure; Macular Degeneration; Male; Retinal Neovascularization; Vascular Endothelial Growth Factor A; Visual Acuity; Vitreous Body

2010
VEGF-A165b is cytoprotective and antiangiogenic in the retina.
    Investigative ophthalmology & visual science, 2010, Volume: 51, Issue:8

    Topics: Angiogenesis Inhibitors; Animals; Animals, Newborn; Aptamers, Nucleotide; Cell Movement; Cell Survival; Cells, Cultured; Cytoprotection; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Endothelium, Vascular; Epithelial Cells; Half-Life; Humans; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor Binding Proteins; Mice; Mice, Inbred C57BL; Rats; Recombinant Proteins; Retinal Neovascularization; Retinal Vessels; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2

2010
[Retinal angiomatous proliferation with associated pigment epithelium detachment: anti-VEGF therapy].
    Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2011, Volume: 108, Issue:3

    Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Choroidal Neovascularization; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Indocyanine Green; Intravitreal Injections; Macular Degeneration; Male; Ophthalmoscopes; Ranibizumab; Retina; Retinal Detachment; Retinal Neovascularization; Retrospective Studies; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Visual Acuity

2011
Changes in retinal neovascularization after pegaptanib (Macugen) therapy in diabetic individuals.
    Ophthalmology, 2006, Volume: 113, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Aptamers, Nucleotide; Diabetic Retinopathy; Female; Fluorescein Angiography; Humans; Injections; Macular Edema; Male; Middle Aged; Randomized Controlled Trials as Topic; Retinal Neovascularization; Retrospective Studies; Vascular Endothelial Growth Factor A; Visual Acuity; Vitreous Body

2006
What we don't know about avastin might hurt us.
    Archives of ophthalmology (Chicago, Ill. : 1960), 2006, Volume: 124, Issue:10

    Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Humans; Ranibizumab; Retinal Neovascularization; Vascular Endothelial Growth Factor A

2006
Neovascular changes after pegaptanib in diabetics.
    Ophthalmology, 2007, Volume: 114, Issue:3

    Topics: Aptamers, Nucleotide; Diabetic Retinopathy; Humans; Randomized Controlled Trials as Topic; Retinal Neovascularization; Vascular Endothelial Growth Factor A

2007
Anti-VEGF therapy: comparison of current and future agents.
    Eye (London, England), 2008, Volume: 22, Issue:10

    Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Choroidal Neovascularization; Forecasting; Humans; Ranibizumab; Retinal Neovascularization; Vascular Endothelial Growth Factor A

2008